Mainz Biomed N V (MYNZ)

Jun 12, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Down 1.9% – Here’s What Happened - Defense World

Jun 12, 2025

Jun 11, 2025

(MYNZ) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 11, 2025

Jun 10, 2025

Mainz Biomed (MYNZ) Advances PancAlert Project for Pancreatic Ca - GuruFocus

Jun 10, 2025

Jun 10, 2025

Mainz Biomed Initiates Feasibility Study Of PancAlert Blood Test For Pancreatic Cancer Detection - Nasdaq

Jun 10, 2025

Jun 10, 2025

Mainz Biomed Initiates Feasibility Study Of Biomarker Panel In Pancreatic Cancer Project - MarketScreener

Jun 10, 2025

Jun 10, 2025

Mainz Biomed (MYNZ) Advances PancAlert Project for Pancreatic Cancer Detection | MYNZ Stock News - GuruFocus

Jun 10, 2025

Jun 10, 2025

Mainz Biomed Initiates Feasibility Phase for Non-Invasive Pancreatic Cancer Screening Test in PancAlert Project - Nasdaq

Jun 10, 2025

Jun 10, 2025

Mainz initiates feasibility study of biomarker panel in PancAlert project - TipRanks

Jun 10, 2025

Jun 10, 2025

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project - The Manila Times

Jun 10, 2025

Jun 05, 2025

Mainz Biomed N.V. Shareholders Approve Key Proposals at Annual Meeting - TipRanks

Jun 05, 2025

May 22, 2025

Maxim Group to Act as Sole Placement Agent for MYNZ Offering | M - GuruFocus

May 22, 2025

May 21, 2025

Mainz Biomed N.V. Secures $4 Million Through Securities Offering - TipRanks

May 21, 2025

May 21, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Up 5.4% – What’s Next? - Defense World

May 21, 2025

May 20, 2025

Mainz Biomed (MYNZ) Prices $4M Follow-On Offering - GuruFocus

May 20, 2025

May 20, 2025

Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants - The Manila Times

May 20, 2025

May 19, 2025

Maxim Group to Act as Sole Placement Agent for MYNZ Offering | MYNZ Stock News - GuruFocus

May 19, 2025

May 19, 2025

Mainz Biomed Announces Pricing of $4 Million Follow-On Offering and Warrant Amendments - Nasdaq

May 19, 2025

May 19, 2025

Cancer Detection Company Mainz Biomed Raises Fresh $4M: Key Details of Share and Warrant Offering - Stock Titan

May 19, 2025

May 19, 2025

Mainz Biomed stock plunges to 52-week low of $2.18 amid market challenges - Investing.com Nigeria

May 19, 2025

May 19, 2025

Trend Tracker for (MYNZ) - news.stocktradersdaily.com

May 19, 2025

May 16, 2025

Mainz Biomed to update on CRC screening study by end of summer - Investing.com South Africa

May 16, 2025

May 16, 2025

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study - GlobeNewswire

May 16, 2025

May 16, 2025

Mainz Biomed Plans Interim Readout For EAArly DETECT 2 CRC Study - Nasdaq

May 16, 2025

May 16, 2025

Revolutionary Cancer Prevention: Mainz Biomed Combines AI and mRNA in 2,000-Patient Colorectal Screening Trial - Stock Titan

May 16, 2025

May 14, 2025

MYNZ Stock Update: Maxim Group's Role as Manager | MYNZ Stock News - GuruFocus

May 14, 2025

May 02, 2025

Mainz Biomed to hold annual meeting on June 2 - Investing.com Australia

May 02, 2025

May 02, 2025

Mainz Biomed to hold annual meeting on June 2 By Investing.com - Investing.com Canada

May 02, 2025

May 02, 2025

Mainz Biomed Prepares for June 2025 Annual General Meeting - TipRanks

May 02, 2025

Apr 30, 2025

Stocks of Mainz Biomed N.V (MYNZ) are poised to climb above their peers - Sete News

Apr 30, 2025

Apr 29, 2025

Investing in Mainz Biomed N.V (MYNZ): What You Must Know - knoxdaily.com

Apr 29, 2025

Apr 29, 2025

Mainz Biomed Enters into Technology Partnership with EDX Medical Group - MSN

Apr 29, 2025

Apr 29, 2025

MYNZ Partners with EDX Medical to Enhance Diagnostic Offerings i - GuruFocus

Apr 29, 2025

Apr 29, 2025

Strategic Partnership: Mainz Biomed and EDX Medical Join Forces to Transform Early Cancer Detection in UK Market - Stock Titan

Apr 29, 2025

Apr 29, 2025

Mainz Biomed (MYNZ) Sees Revenue Surge Amid Strong Demand for Co - GuruFocus

Apr 29, 2025

Apr 29, 2025

Mainz Biomed N.V (NASDAQ: MYNZ) Is Expected To Soar To Higher Prices In The Months To Come. - Marketing Sentinel

Apr 29, 2025

Apr 28, 2025

Mainz Biomed advances in FDA approval for CRC test By Investing.com - Investing.com South Africa

Apr 28, 2025

Apr 28, 2025

Mainz Biomed advances in FDA approval for CRC test - Investing.com Australia

Apr 28, 2025

Apr 28, 2025

The Mainz Biomed N.V (MYNZ) Stock Is Headed for a Correction - uspostnews.com

Apr 28, 2025

Apr 28, 2025

MYNZ: Mainz Biomed Advances Cancer Detection with New Feasibilit - GuruFocus

Apr 28, 2025

Apr 28, 2025

Mainz Biomed N.V. Reports Q1 2025 Accomplishments and FDA Premarket Approval Progress - Nasdaq

Apr 28, 2025

Apr 28, 2025

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval - GlobeNewswire

Apr 28, 2025

Apr 28, 2025

Mainz Biomed's Game-Changing Cancer Test Shows 98% Accuracy as Company Expands European Presence - Stock Titan

Apr 28, 2025

Apr 28, 2025

Mainz Biomed (NASDAQ:MYNZ) Short Interest Down 48.7% in April - Defense World

Apr 28, 2025

Apr 27, 2025

Mainz Biomed (MYNZ) Sees Revenue Surge Amid Strong Demand for ColoAlert - GuruFocus

Apr 27, 2025

Apr 23, 2025

Long Term Trading Analysis for (MYNZ) - news.stocktradersdaily.com

Apr 23, 2025

Apr 23, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Up 3.9% – What’s Next? - Defense World

Apr 23, 2025

Apr 22, 2025

Colorectal to Pancreatic: Mainz Biomed Expands Reach in Early Cancer Detection - Markets Herald

Apr 22, 2025